newsfilter
← Latest News
PR Newswire·

Compugen Reports First Quarter 2026 Results

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by...